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Abstract
Background: Prenatal genetic testing is an essential part of routine prenatal care. Yet, obstetricians often lack the time to provide
comprehensive prenatal genetic testing education to their patients. Pregnant women lack prenatal genetic testing knowledge,
which may hinder informed decision-making during their pregnancies. Due to the rapid growth of technology, mobile apps are
a potentially valuable educational tool through which pregnant women can learn about prenatal genetic testing and improve the
quality of their communication with obstetricians. The characteristics, quality, and number of available apps containing prenatal
genetic testing information are, however, unknown.
Objective: This study aims to conduct a firstreview to identify, evaluate, and summarize currently available mobile apps that
contain prenatal genetic testing information using a systematic approach.
Methods: We searched both the Apple App Store and Google Play for mobile apps containing prenatal genetic testing information.
The quality of apps was assessed based on the criteria adopted from two commonly used and validated mobile app scoring systems,
including the Mobile Application Rating Scale (MARS) and the APPLICATIONS evaluation criteria.
Results: A total of 64 mobile apps were identified. Of these, only 2 apps were developed for a specific prenatal genetic test.
All others were either pregnancy-related (61/64, 95%) or genetics-related (1/64, 2%) apps that provided prenatal genetic testing
information. The majority of the apps (49/64, 77%) were developed by commercial companies. The mean quality assessment
score of the included apps was 13.5 (SD 2.9), which was equal to the average of possible theoretical score. Overall, the main
weaknesses of mobile apps in this review included the limited number of prenatal genetic tests mentioned; incomprehensiveness
of testing information; unreliable and missing information sources; absence of developmental testing with users (not evidence
based); high level of readability; and the lack of visual information, customization, and a text search field.
Conclusions: Our findings suggest that the quality of mobile apps with prenatal genetic testing information must be improved
and that pregnant women should be cautious when using these apps for prenatal genetic testing information. Obstetricians should
carefully examine mobile apps before referring any of them to their patients for use as an educational tool. Both improving the
https://mhealth.jmir.org/2021/10/e30404
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quality of existing mobile apps, and developing new, evidence-based, high-quality mobile apps targeting all prenatal genetic tests
should be the focus of mobile app developers going forward.
(JMIR Mhealth Uhealth 2021;9(10):e30404) doi: 10.2196/30404
KEYWORDS
mobile applications; prenatal genetic testing; pregnancy; review; evaluation

Introduction
Prenatal genetic testing, a set of genetic tests used to detect
potential fetal disease risk, is an essential part of routine prenatal
care [1,2]. Information provided by these tests allows pregnant
women to make informed decisions about their pregnancy,
including preparation for affected births, early management of
infants with genetic disorders, and termination of affected
pregnancies [1,3-5]. Although prenatal genetic testing is
important for pregnant women, obstetricians often have
insufficient time to provide comprehensive education about
prenatal genetic testing in prenatal care [6,7]. Studies have found
that pregnant women lack prenatal genetic testing knowledge,
which may hinder informed decision-making during their
pregnancies [4,8,9].
Mobile apps have been used to assist patients in accessing health
information, facilitate engagement with their physicians, and
strengthen patient-provider communication and relationships
[10-12]. Lay people also perceive health information provided
by apps to be accurate and trustworthy [13]. Among apps with
medical information, pregnancy-related apps are the most
common [14,15]. Nevertheless, the characteristics, quality, and
number of available apps containing prenatal genetic testing
information are unknown.
To fill this knowledge gap, we used a systematic approach to
identify existing apps containing prenatal genetic testing
information and summarize their characteristics. We then
adapted existing app evaluation tools [16-18] to evaluate the
quality of these apps. We believe our findings will have the
potential to help obstetricians become familiar with prenatal
genetic testing apps and make recommendations to their patients.
Our results can assist researchers and app developers to
recognize the strengths and limitations of existing apps that
contain information pertaining to prenatal genetic testing, as
well as to design apps that better meet the needs of pregnant
women.

Methods
Overview
Because this study did not involve risk to human subjects, it
was exempted from institutional review board oversight at Texas
A&M University. A prenatal genetic counselor at a large

https://mhealth.jmir.org/2021/10/e30404

XSL• FO
RenderX

medical center and a certified health education specialist who
is an expert in prenatal genetic education guided, oversaw, and
reviewed the research process and findings.

App Search
Figure 1 summarizes the search, screening, and selection
procedures for the eligible prenatal genetic testing apps.
Specifically, this process included four steps. First, 3 members
of the research team (KW, RA, and JG) conducted a search on
both the Apple App Store (iOS) and Google Play (Android) for
apps with prenatal genetic testing information, between January
28, 2020, and March 23, 2020. The following search terms were
used: “pregnancy,” “prenatal,” “pregnant,” “genetic testing,”
“genetic screening,” “pregnancy screening,” “prenatal
screening,” “prenatal screening test,” “prenatal diagnostic test,”
“carrier testing,” “expanded carrier screening,” “amniocentesis,”
“chorionic villus sampling,” “non-invasive prenatal testing,”
“non-invasive prenatal screening,” “cell free DNA screening,”
“cell free DNA testing,” “MaterniT21,” “Harmony,”
“Panorama,” “QNatal,” “percutaneous umbilical blood
sampling,” “cordocentesis,” “nuchal translucency scan,” “nuchal
translucency ultrasound,” “quad screen,” “quadruple screen,”
“quadruple test,” “first-trimester screening,” “second-trimester
screening,” “modified sequential screening,” “sequential
screening,” “alpha-fetoprotein screening,” “maternal serum
screening,” “prenatal genetic screening test,” “prenatal genetic
screening,” and “prenatal genetic testing”.
A total of 3795 apps were identified. In the second step, we
used very few exclusion criteria for the initial screening in order
to maximize the number of potential apps selected. A total of
2902 apps were excluded using the following exclusion criteria:
(1) apps that were not relevant to prenatal genetic testing,
pregnancy, and/or genetics, and (2) apps that were not in
English. In the third step, we excluded apps that were duplicated
within the Apple App Store (iOS) and in Google Play (Android).
In the fourth step, a total of 414 apps were downloaded and
thoroughly assessed. Among these, 28 apps were excluded
because of workability issues, such as apps that could not be
successfully downloaded or opened, and/or those that needed
a specific user account from a hospital or clinic for access.
Moreover, 284 apps were excluded due to the lack of prenatal
genetic testing information, and 38 apps were excluded because
of their duplication in both the Apple App Store and Google
Play. Thus, our final sample consisted of 64 apps.

JMIR Mhealth Uhealth 2021 | vol. 9 | iss. 10 | e30404 | p. 2
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Figure 1. The selection process of mobile apps containing prenatal genetic testing information. aThe apps were excluded by reading the app titles and
descriptions.

Data Extraction
The entire research team assessed, extracted, and summarized
detailed information from the included 64 apps (Multimedia
Appendix 1). Extracted information included app name,
operating system (ie, iOS or Android), app description, types
of prenatal genetic testing mentioned in those apps, prenatal
genetic test procedures mentioned therein, information on the
timing of prenatal genetic tests, reliability or accuracy of
prenatal genetic tests included, interpretation of the results of
those prenatal genetic tests, specific disorders mentioned,
prenatal genetic testing information citations, customer ratings,
and cost. Moreover, according to the Mobile Application Rating
Scale (MARS) app classification [18], we also extracted the
app developer information (ie, details of the commercial
company, hospital, or nongovernmental organization). Finally,
based on the content of the apps, we utilized the Flesch-Kincaid
grade level assessment to determine the readability level of the
apps selected for further analysis.
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App Quality Assessment
To evaluate the quality of the selected apps, we developed the
App Quality Assessment Scoring System (AQASS) by adapting
two common app evaluation tools—MARS [18] and the
“APPLICATIONS” evaluation criteria [16,17]. The AQASS
was used to assess 16 items in each app, including the number
of prenatal genetic tests mentioned, comprehensiveness,
information quality, quality of information sources, evidence
base, readability, visual prenatal genetic testing information,
customization, interactivity, text search field, ease of navigation,
app layout, visual appeal, interdevice compatibility,
connectivity, and price. Table 1 lists the detailed criteria for
each item in AQASS. Possible AQASS scores ranged from 0
to 27, with a higher score representing higher app quality.
Following the reliability checking procedure outlined in previous
research [19,20], 2 raters on the team (RA and HH) used the
AQASS criteria to independently score each app, after which
interrater reliability was assessed using the Gwet AC1
calculation [21]. Findings suggest a strong interrater reliability
between the two raters with a coefficient of 0.86 [22].
JMIR Mhealth Uhealth 2021 | vol. 9 | iss. 10 | e30404 | p. 3
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Table 1. App Quality Assessment Scoring System (AQASS) ratings of mobile apps (N=64) containing prenatal genetic testing information.
Criterion and description

AQASS score

Frequency distribution (%)

Using the general term “(prenatal) genetic testing” only

0

3

1-5 prenatal genetic tests

1

67

6-10 prenatal genetic tests

2

30

All 10 prenatal genetic tests

3

0

0

2

Number of prenatal genetic tests mentioned

Comprehensiveness of information
Only mentioned the name of the prenatal genetic test

Having information in 1 or 2 of the following 5 categories: test procedures, timing of the 1
tests, reliability or accuracy of the tests, interpretation of test results, and specific diseases
or conditions to be tested for

25

Having information in 3 or 4 of the following 5 categories: test procedures, timing of the 2
tests, reliability or accuracy of the tests, interpretation of test results, and specific diseases
or conditions to be tested for

38

Having information in all of the following categories: test procedures, timing of the tests, 3
reliability or accuracy of the tests, interpretation of test results, and specific diseases or
conditions to be tested for

36

Quality of information
Information too general to assess quality

0

3

Most information is incorrect

1

2

Some incorrect and/or out-of-date information

2

25

Correct and up-to-date information

3

70

No reference identified

0

75

Questionable/unreliable source(s)

1

3

Source from hospitals, specific obstetricians-gynecologists, or peer reviewed articles

2

13

Source from authoritative organizations, such as the American College of Obstetricians
and Gynecologists

3

9

0

98

Reliable information sources

Evidence base
App had not been trialed or tested

App had been tested (eg, acceptability, usability, and satisfaction ratings) and had positive 1
outcomes in studies that were not randomized control trials (RCTs), and there was no
contradictory evidence.

2

App had been trialed and outcome tested in 1-2 RCTs indicating positive results

2

0

App had been trialed and outcome tested in >3 high quality RCTs indicating positive results 3

0

Readabilitya
Not applicableb

0

3

>6th grade

1

95

≤6th grade

2

2

Absent

0

92

Present

1

8

Absent

0

100

Present

1

0

Visual informationc

Customizationd

https://mhealth.jmir.org/2021/10/e30404
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Criterion and description

AQASS score

Frequency distribution (%)

Absent

0

31

Present

1

69

Absent

0

61

Present

1

39

Hard to navigate

0

14

Easy to navigate

1

86

Inappropriate, unclear, and/or some options difficult to select, locate, find, or read

0

3

Appropriate, clear, and able to select, locate, find, or read items

1

97

Unprofessional or unappealing

0

2

Professional and appealing

1

98

iPhone or Android phone

0

41

iPhone and Android phone

1

59

Internet not required

0

58

Internet required

1

42

Paid

0

0

Free

1

100

Interactivitye

Text search function

Navigation ease

Layout of the app

Visual appeal

Interdevice compatibility

Connectivity

Price

a

Readability was assessed by Flesch-Kincaid grade level assessment. According to Weiss [23], mobile health apps are recommended to have a reading
level of sixth grade or below for general public use.
b

App did not have enough text and/or complete sentences to allow for the calculation of Flesch-Kincaid grade level for readability.

c

Visual information was defined as the presence in the app of photos, images, tables, figures, and videos to demonstrate pregame genetic tests

d

Customization referred to a function that allows users to input prenatal genetic test results, testing dates, and other information in settings or preferences
of the mobile app.
e

Interactivity allowed users to provide feedback to the developers, offer reminders on the timing of prenatal genetic testing, have a chatroom function,
and allow sharing information onto the social media.

Results

provided prenatal genetic testing information were either
pregnancy-related (61/64, 95%) or genetics (1/64, 2%) apps.

Among 64 evaluated apps, only 2 (3.1%) apps were specifically
developed for prenatal genetic testing. NIPT Insights, developed
by Five Minutes Ltd., introduced noninvasive prenatal testing
(NIPT) and compared it with first-trimester screening,
triple/quad screening, anatomy ultrasound, chorionic villus
sampling (CVS), and amniocentesis. Similarly, cfDNA
Predictive Value Calculator (Perinatal Quality Foundation)
offered links to a number of scientific articles regarding NIPT,
and it provided users with the ability to calculate both positive
and negative predictive values of NIPT. All other apps that

Table 2 summarizes the key characteristics of those 64 apps.
Specifically, all 64 apps could be downloaded at no cost. Of
these, 5 (8%) offered an optional upgrade, which were
downloaded and assessed. However, upgrading did not provide
any further prenatal genetic testing information. The majority
of the apps (49/64, 77%) were created by commercial
companies, and over half of the apps (38/64, 59%) were
compatible with both the Android and iOS operating systems.
Only 52 (81%) apps had a customer rating. With a theoretical
range of 1 to 5 stars, the mean rating was 4.5 (SD 0.6; range
2.0-5.0).
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Table 2. Descriptive statistics of the mobile apps (N=64) containing prenatal genetic testing information.
Characteristic and category

Value, n (%)

Type of developer
App created by commercial companies

49 (77)

App created by hospitals

11 (17)

App created by non-governmental organizations

3 (5)

Apps created by the government (ie, California Department of Public Health)

1 (2)

Operating system
Android only

15 (23)

iOS only

11 (17)

Android and iOS

38 (59)

Type of prenatal genetic tests mentioned
Amniocentesis

49 (77)

CVSa

49 (77)

First trimester screening (NTb screening)

46 (72)

Triple/quad screening

44 (69)

Cell-free DNA testing or NIPTc

35 (55)

Anatomy ultrasound

26 (41)

Cordocentesis

10 (16)

Expanded carrier screening

8 (13)

First trimester screening (blood test)

8 (13)

Genetic screening (prenatal) in general

7 (11)

Carrier screening

6 (9)

Prenatal genetic test procedures mentioned
Amniocentesis

37 (58)

CVS

36 (56)

First trimester screening (NT screening)

34 (53)

Cell-free DNA testing or NIPT

25 (39)

Triple/quad screening

17 (27)

Cordocentesis

9 (14)

Anatomy ultrasound

5 (8)

Carrier screening

4 (6)

First trimester screening (blood test)

3 (5)

Expanded carrier screening

1 (2)

Not reported

17 (27)

Timing of prenatal genetic tests mentioned
CVS

45 (70)

Amniocentesis

44 (69)

First trimester screening (NT screening)

40 (63)

Triple/quad screening

38 (59)

Cell-free DNA testing or NIPT

31 (48)

Anatomy ultrasound

23 (36)

Cordocentesis

9 (14)
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Value, n (%)

First trimester screening (blood test)

8 (13)

Carrier screening

3 (5)

Expanded carrier screening

1 (2)

Genetic screening (prenatal) in general

1 (2)

Not reported

5 (8)

Reliability or accuracy of prenatal genetic tests mentioned
Cell-free DNA testing or NIPT

23 (36)

Amniocentesis

21 (33)

First trimester screening (NT screening)

13 (20)

CVS

12 (19)

Triple/quad screening

12 (19)

Cordocentesis

2 (3)

Carrier screening

1 (2)

Expanded carrier screening

1 (2)

First trimester screening (blood test)

1 (2)

Anatomy ultrasound

1 (2)

Not reported

33 (52)

Interpretation of potential results of prenatal genetic tests
Triple/quad screening

19 (30)

Cell-free DNA testing or NIPT

13 (20)

Amniocentesis

12 (19)

First trimester screening (NT screening)

9 (14)

Expanded carrier screening

8 (13)

CVS

8 (13)

Carrier screening

3 (5)

Genetic screening (prenatal) in general

1 (2)

Not reported

36 (56)

Specific disorder(s) mentioned
Trisomy 21 (Down syndrome)

53 (83)

Trisomy 18 (Edward syndrome)

33 (52)

Cystic fibrosis

29 (45)

Trisomy 13 (Patau syndrome)

18 (28)

Sickle cell anemia

14 (22)

Tay-Sachs disease

11 (17)

Spinal muscular atrophy

8 (13)

Neural tube defect (general)

3 (5)

Spina bifida

15 (23)

Anencephaly

6 (9)

Thalassemia

3 (5)

Fragile X syndrome

2 (3)

Huntington disease

2 (3)

Muscular dystrophy

2 (3)

Klinefelter syndrome

1 (2)
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Characteristic and category

Value, n (%)

Prader-Willi syndrome

1 (2)

Trisomy 16

1 (2)

Turner syndrome

1 (2)

Not reported

9 (14)

Citation for prenatal genetic testing information

a

No

48 (75)

Yes (reliable source)

14 (22)

Yes (non-reliable source)

2 (3)

Costd: $0

64 (100)

Customer ratinge, mean (SD); range

4.5 (0.6); 2.0-5.0

CVS: chorionic villus sampling.

b

NT: nuchal translucency.

c

NIPT: noninvasive prenatal testing.

d

Five apps had an optional upgrade fee but upgrading did not affect the amount of prenatal genetic testing information available to the user.

e

Only 52 of the 64 apps (81.3%) had customer ratings.

A total of 10 different types of prenatal genetic tests were
mentioned across all apps, including carrier screening, expanded
carrier screening, first-trimester screening (blood test),
first-trimester screening (nuchal translucency screening),
cell-free DNA testing or NIPT, CVS, amniocentesis, triple/quad
screening, anatomy ultrasound, and cordocentesis/percutaneous
umbilical blood sampling. Amniocentesis and CVS were most
common types of prenatal genetic tests referred to in apps
(49/64, 77% for both), whereas carrier screening (6/64, 9%)
was the least mentioned.
All apps specifically referred to 17 genetic disorders tested for
by prenatal genetic testing; these included testing for the
following disorders: trisomy 21 (53/64, 83%), trisomy 18 (33/64,
52%), cystic fibrosis (29/64, 45%), trisomy 13 (18/64, 28%),
spina bifida (15/64, 23%), sickle cell anemia (14/64, 22%),
Tay-Sachs disease (11/64, 17%), spinal muscular atrophy (8/64,
13%), anencephaly (6/64, 9%), neural tube defect as a general
term (3/64, 5%), thalassemia (3/64, 5%), Fragile X syndrome
(2/64, 3%), Huntington disease (2/64, 3%), muscular dystrophy
(2/64, 3%), Klinefelter syndrome (1/64, 2%), Prader-Willi
syndrome (1/64, 2%), trisomy 16 (1/64, 2%), and Turner
syndrome (1/64, 2%). Nevertheless, 14.1% (9/64) of the apps
did not mention any genetic disorders that could be identified
by prenatal genetic testing. Information that was missing in the
reviewed apps included context about the interpretation of test
results (36/64, 56%), the reliability or the accuracy of prenatal
genetic tests (33/64, 52%), testing procedures (17/64, 27%),
and testing time (5/64, 8%). In terms of references and citations
found in these apps, only 14 of 64 apps (22%) included reliable
sources (eg, the Mayo Clinic, the American Pregnancy
Association, and the American College of Obstetricians and
Gynecologists [ACOG]) to support their prenatal genetic testing
information.
Table 1 summarizes the AQASS ratings for the quality of the
64 apps we evaluated. With a possible score range of 0 to 27,
the mean score for all apps was 13.5 (SD 2.89; range 5-18). In
https://mhealth.jmir.org/2021/10/e30404
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particular, a majority of the apps were found to be visually
appealing (63/64, 98%), have appropriate and clear layouts
(62/64, 97%), easy to navigate (55/64, 86%), contain
interactivity functions (44/64, 69%), and require no internet to
access once downloaded (37/64, 58%). Nevertheless, none of
the apps included all types of prenatal genetic tests. Most apps
(43/64, 67%) reported only 1 to 5 types of prenatal genetic tests.
Only 23 (36%) of all the evaluated apps addressed procedures,
timing, reliability or accuracy, and interpretation of the results
of the prenatal genetic tests. Although 45 (70%) of the apps
presented correct and up-to-date information, merely 8 apps
(13%) provided reliable information sources from hospitals,
specific obstetricians-gynecologists, and/or peer reviewed
articles, or referenced authoritative organizations such as the
ACOG (6/64, 9%). Furthermore, a large percentage of the apps
had a reading level higher than the sixth grade (61/64, 95%),
did not include any visual information for prenatal genetic
testing (eg, photos, images, tables, figures, and videos) (59/64,
92%), and lacked a text search field (39/64, 61%). None of the
apps had a customization function to allow for the tailoring of
the prenatal genetic information to the patients’ circumstances
(eg, inputting gestational weeks as well as prenatal genetic
testing dates and results in settings or preferences). Nearly all
apps (63/64, 98%) had not been tested by research studies to
determine their quality and efficacy.

Discussion
Principal Findings
It is important for pregnant women to understand prenatal
genetic testing in order to make informed decisions about
whether or not to utilize these tests during their pregnancy [4].
Apps are a potential educational tool to help pregnant women
understand such complex information [24]. To our knowledge,
our study is the first systematic review of apps containing
prenatal genetic testing information. We found 64 apps currently
available that provide information about prenatal genetic testing.
JMIR Mhealth Uhealth 2021 | vol. 9 | iss. 10 | e30404 | p. 8
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Nevertheless, none of those apps presented comprehensive
information about all prenatal genetic tests.
Our results showed that commercial companies had developed
the majority of the 64 apps with prenatal genetic testing
information we found. We also noticed that approximately
one-third of all evaluated apps contained incorrect and/or
out-of-date information. It is recommended that developers in
commercial companies collaborate with a team of health care
professionals, including obstetricians, geneticists, and genetic
counselors to design apps with accurate and up-to-date
information. Moreover, due to the rapid advancement of
genomic technologies, information and guidelines regarding
prenatal genetic testing may evolve periodically [25]. Thus,
developers should review their apps constantly and update
information as needed.
The average AQASS score of the 64 apps containing prenatal
genetic testing information for our final sample was 13.5, which
was equal to the mean score of the possible theoretical AQASS
score (range 0-27). This low score was in line with a previous
review that suggested that the quality of genetics and genomics
apps that need improvement [19]. The low scores of the apps
we evaluated was mainly due to the limited number of prenatal
genetic tests mentioned, incomprehensiveness of testing
information, unreliable and missing information sources;
absence of developmental and clinical testing with users; high
readability levels; and the lack of visual information presented,
customization options, and a text search field.
Unfortunately, the regulation of health apps has not been well
established in the United States. Although the Food and Drug
Administration (FDA) has published a policy regulating medical
health apps, only mobile apps classified as medical devices are
currently under federal oversight and require the FDA approval
before they are released to the public [26,27]. Because the FDA
does not regulate health apps focused on providing health
information [26,27], the often-low quality we found in these
apps that include information of prenatal genetic testing can
cause pregnant women to be exposed to incomplete, unreliable
information regarding prenatal genetic testing. As such,
comprehensive regulatory standards and guidelines for these
apps are urgently required.

Clinical and Research Implications
Our study has important clinical and research implications. First,
due to the lack of high-quality and comprehensive apps that
provide prenatal genetic testing information, we caution
obstetricians to be prepared to address the questions raised by
patients who may have previously obtained incorrect and
incomplete information from those apps. Second, obstetricians
should also be aware of the limitations of the apps with prenatal
genetic testing information when communicating with their
patients. Moreover, establishing policies to regulate apps that
include prenatal genetic testing information is warranted.
Finally, from both research and clinical standpoints, the creation
of a high-quality app specifically designed for prenatal genetic
testing that has been evaluated using a randomized control trial
to test its efficacy in improving pregnant women’s prenatal
genetic testing decision-making is recommended.
https://mhealth.jmir.org/2021/10/e30404
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Strengths and Limitations
There are several limitations to this study. As we only reviewed
apps with information on prenatal genetic testing in English,
there may be apps developed in languages other than English
that were not included in this review. Similarly, our app search
was conducted in the United States. Future researchers may
consider changing platform and search settings to include apps
available in countries outside the United States to allow for a
broader search. Furthermore, as a team, we carefully conducted
the app search together and asked 3 additional researchers to
independently check our search results. Some apps, however,
may have been overlooked. As the app search was concluded
on March 23, 2020, new apps with prenatal genetic testing
information may have become available after that date.
Despite these limitations, this study has a number of strengths.
It is a unique study and the first of its kind attempting to identify
apps containing prenatal genetic testing information. After
screening a total of 3795 apps on the Apple App Store and
Google Play platforms, we identified 64 apps. In addition, we
also carefully examined each app to present a thorough summary
of the information they contained. Beyond reporting the
characteristics of the identified apps, we developed the AQASS
to capture a detailed overview of the quality of the apps we
reviewed, as most apps were not created with the primary
purpose of conveying prenatal genetic testing to pregnant
women. Our AQASS was based on commonly used and
validated app scoring systems (ie, MARS and APPLICATIONS)
[16-18]. We adopted both these systems because several items
of MARS (eg, “Quality of information: Is app content correct,
well written, and relevant to the goal/topic of the app?”) and
APPLICATIONS (eg, “advertisements” and “subjective
presentation”) were not applicable to the evaluation of the apps
that provide prenatal genetic testing information in our study.
Conversely, some items from either MARS (eg, “Evidence base:
Has the app been trialed/tested?”) or APPLICATIONS (eg,
“connectivity” and “navigation ease”) were found to be suitable
for the evaluation of apps that include information on prenatal
genetic testing. Beyond the use of AQASS for our study, it can
also be adopted to assess other apps that were not originally
designed to primarily address the specific topic under evaluation.
It should be noted that the reliability and validity of AQASS
also need to be further examined in the future.

Conclusions
This study is the first to extensively search apps containing
information on prenatal genetic testing in both the Apple App
Store and Google Play, summarize their characteristics, and
assess their quality. We identified 64 available apps containing
information about prenatal genetic testing and found that the
quality of those apps needs to be improved. Additionally, none
of the apps we evaluated were specifically designed to introduce
all prenatal genetic tests. As such, pregnant women should be
cautious when using these apps for prenatal genetic testing
information. Obstetricians should carefully examine apps before
any recommendation is made for their use as an educational
tool. Improving the quality of existing apps and developing
new, evidence-based, high-quality apps with a targeted focus
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